Valion Bio names CFO Lisa Wolf president, COO after CEO Handley exits
Reuters2026/09/01 10:09- Valion Bio appointed CFO Lisa Wolf as president and COO, taking executive leadership following former CEO Michael K. Handley’s departure.
- Board added Jared Malbin, COO of Lucid Capital Markets with broker-dealer operations, compliance, finance, capital-markets experience.
- Thomas Jensen joined as director; he is CEO, co-founder, director of Allarity Therapeutics with biotech and oncology leadership experience.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Marriott International, LG Electronics Jointly Develop Cloud-Based Guest Room Entertainment, Technology Platform
From GPU to 'Shovel Sellers': Deutsche Bank Covers AI Hardware Sector for the First Time, Laser Duo Lumentum (LITE.US) and Coherent (COHR.US) Both Receive 'Buy' Ratings
Deutsche Bank has recently officially covered the AI hardware sector and put forward a key question: In today's era of artificial intelligence, what truly constitutes essential demand?
GFL Environmental Closes the Acquisition of SECURE Waste Infrastructure
Crypto prices
More
